SCHEMBL19291985

SCHEMBL19291985

O=C(Cc1ccc(-c2ccc(OCCN3CCNCC3)cc2F)nc1)NCc1ccnc(F)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 7/20 0.43
CYP3A4 P08684 3/20 0.41
SRC P12931 2/20 0.40
ROCK2 O75116 1/20 0.40
TUBB4A P04350 2/20 0.38
TUBB P07437 2/20 0.38
TUBA3C P0DPH7 2/20 0.38
TUBA1B P68363 2/20 0.38
TUBA4A P68366 2/20 0.38
TUBB4B P68371 2/20 0.38
TUBB3 Q13509 2/20 0.38
TUBB2A Q13885 2/20 0.38
TUBB8 Q3ZCM7 2/20 0.38
TUBA3E Q6PEY2 2/20 0.38
TUBA1A Q71U36 2/20 0.38
TUBA1C Q9BQE3 2/20 0.38
TUBB6 Q9BUF5 2/20 0.38
TUBB2B Q9BVA1 2/20 0.38
TUBB1 Q9H4B7 2/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL253864 0.92 ROCK1 (0.43) ROCK1CYP3A4SRCTUBB4ATUBB
SCHEMBL19291993 0.90 ROCK1 (0.45) ROCK1CYP3A4SRCROCK2TUBB4A
SCHEMBL19291988 0.89 ROCK1 (0.45) ROCK1CYP3A4SRCROCK2TUBB4A
SCHEMBL14047243 0.88 ROCK1 (0.42) ROCK1CYP3A4SRCROCK2TUBB4A
SCHEMBL19291990 0.88 ROCK1 (0.43) ROCK1CYP3A4SRCROCK2TUBB4A
SCHEMBL12782547 0.85 ROCK1 (0.42) ROCK1CYP3A4SRCTUBB4ATUBB
SCHEMBL19291997 0.85 SRC (0.54) ROCK1CYP3A4SRCROCK2TUBB4A
SCHEMBL10169296 0.84 ROCK1 (0.42) ROCK1CYP3A4SRCTUBB4ATUBB
SCHEMBL255076 0.82 SRC (0.43) ROCK1CYP3A4SRCTUBB4ATUBB
SCHEMBL19291987 0.81 SRC (0.40) ROCK1CYP3A4SRCROCK2TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558085-B1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER ATHENEX INC (US) 2017-08-30 EP disclosed